Hepatitis B Virus Cure (2022) - How to Treat Hepatitis B Viral Infection?
The Hepatitis B virus (HBV) is one
of the most common types of viral hepatitis. It causes inflammation of the
liver and affects about 350 million people worldwide. Learn more about the latest
news on HBV cure.
The best way to prevent infection
with this type of hepatitis is through vaccination. However, there are other
methods for treating the disease, including antiviral medications.
HBV around the world:
Hepatitis B patients represent a
quarter of a billion people out of the world's population of 7.6 billion and
every 30 seconds a patient dies because of complications from viral hepatitis,
whether it is B or C.
The problem lies in the spread of
this virus in many places, most notably China, Southeast Asia, Saudi Arabia,
brown Africa, and the South American region near the Amazon basin in Venezuela
and Ecuador.
Hepatitis B virus.
There are two forms of hepatitis B
virus: acute and chronic. Acute hepatitis B occurs when an individual becomes
infected with the virus. This type of infection usually resolves itself within
6 months without any treatment. However, some individuals develop chronic
hepatitis B after being infected by the virus. Chronic hepatitis B is more
serious than acute hepatitis B because it does not resolve itself.
Symptoms Of Hepatitis B Virus
Chronic hepatitis B infection
usually does not cause any symptoms until the immune system has weakened. This
means that patients who do not show signs of the disease may still be infected.
However, some individuals develop symptoms of the disease at an early stage.
These symptoms include fatigue, loss of appetite, nausea, vomiting, abdominal
pain, dark urine, jaundice, itching, and yellow eyes.
Complications of Hepatitis B virus
The problem of the B virus, such as
the C virus, is that it causes cirrhosis and liver cancer, as well as the B
virus which can cause liver cancer before it causes fibrosis, unlike the C
virus, which does not cause liver cancer until after cirrhosis has occurred.
Treatment of hepatitis B
If you have been diagnosed with
chronic hepatitis B, there are several treatments available to help you manage
the condition. These treatments include antiviral medications, such as
lamivudine, adefovir dipivoxil, entecavir, telbivudine, tenofovir disoproxil
fumarate, and pegylated interferon alpha 2a. these drugs help to control viral
replication but are not a definite cure.
How to get rid of hepatitis B?
WHO has hope to eliminate the HBV
virus from the world before 2030.
HBV elimination plan must take place
on two axes
The first axis: is the patients
We divide patients into two groups:
Group I: treatment of active B virus disease
Active B virus patients must take
treatment and their treatment until this moment is for life, but some recent
studies have shown that treatment can be stopped after 3 years only under
specific conditions:
• Absence of cirrhosis of the liver
• Constantly negative PCR analysis
for the virus
• The percentage of surface antigen
in the blood is less than 100
• Follow-up of the patient care
after stopping the treatment for rapid intervention in the event of significant
activity of the virus.
What will happen after stopping treatment in these patients?
If we adhere to the conditions,
stopping treatment may lead to the immune system identifying and eliminating the
virus and reaching the final recovery stage in some cases, but it should be
noted that this should only be done under the supervision of a specialized
doctor.
Therefore, the countries must
provide medicine to patients at cheap prices because the patient needs to take
it for life, so the price must be within his reach.
It is also very important that
governments support research that works on hepatitis B drugs and increase
budgets and spending on them. These patients have the right to be cured of
hepatitis B just like hepatitis C.
It is very important to provide
treatment for B virus patients to reduce the chance of transmitting the
infection to others in addition to the health benefits of the patients.
Group 2: Treatment of inactive HBV
As for dormant B virus patients, the
issue of their treatment is controversial, but we agree that this patient needs
follow-up until we give him a treatment if the virus is active and whether the
virus is inactive or active, these patients, as we mentioned before, have a big
social problem, this patient cannot travel, work, or marry.
It is important to integrate these
patients into society so that they do not have a problem joining work or traveling.
These patients have the right to be treated as normal, especially since most of
them do not have real health problems. A dormant B virus patient has a normal
liver and normal liver functions, so why is he deprived of his right to Marry,
work or travel?
Latest hepatitis B treatment news:
What is the definitive treatment for
HBV?
It is the treatment that eliminates
the B virus completely, as is the case with the C virus.
How can we make sure that the B
virus is eliminated?
First, the surface antigen and my
virus's PCR must be negative for a period of no less than 6 months after
stopping the treatment, and it is preferable if the antibodies to the surface
antigen appear in the blood.
Hepatitis B cure the latest news
Cure to hepatitis B 2021
Roche company July 2021 discovered a
new drug that reduces the replication of the virus because it works on the
protein membrane of the DNA of the virus, and it was tested on animals and on
35 patients who used it for a month.
And the drug will not be alone as we
have already mentioned, but it will be part of a group of medicines that work
on the B virus and the immune system until we reach the best combination that
can eliminate the B virus completely, but this medicine will be one of the very
important medicines and will be tried on large numbers, the main advantage in
this medicine It has no side effects.
Cure to hepatitis B 2022
In July 2022, at the largest
international conference on hepatology, the results of ongoing research on recent
drugs to treat the B virus were presented, and the two studies in this field
are:
The first study, which was carried
out by the company GSK
The drug Piproversin
works to stop the manufacture of virus proteins, including, of course, surface
antigen production. This drug was able to get rid of the surface antigen in
about 30% of patients within six months only, and we are now waiting for the
result of the second part of the study, which includes stopping the treatment
for these patients to ensure that they Continuity of their disposal of surface
antigen production after stopping treatment.
The second study, which was
conducted by Biotechnology Vir
The most important study conducted
by this company was using two drugs together, a drug that stops the manufacture
of virus proteins, as is the case with Piproversin, and another drug that
prevents the virus from entering the liver cell and even delivers it to the
immune lymphocytes to identify it and then eliminate the rest of its peers in
the body.
This formulation was able to
significantly reduce surface antigen production in about 73% of patients, and
this effect persisted after stopping the treatment. We are waiting for the results
in 2023.
Are there complications or serious side effects of these new drugs?
Thanks to God, there are no serious
complications from these drugs.
Will these new drugs be used to treat inactive and active B viruses?
Yes, it will be used to treat both inactive
and active viruses.
Is there a cure for hepatitis B today?
The current studies say that we have
not yet reached the final treatment for the B virus, but we are on the way to
that, and this may take some time, given the events we are witnessing such as
the Covid and the Russian-Ukrainian war, which have cast a shadow over the
speed of scientific research in the whole world, but we hope to get rid of this
damn virus before 2030 solutions.
More details about the final
treatment are in these subtitled videos.
Prevention of hepatitis B
It is the second axis of the plan to
eliminate HBV.
It includes:
First, the vaccinations
It is very important, especially in countries with a high rate of spread of the virus.
The rate of spread of the virus is
divided into 3 degrees:
First, is a high prevalence rate:
that is, more than 8 percent of the population suffers from the B virus, and
this is in the countries that we have already mentioned at the beginning of the
article.
Second, low prevalence: less than 2%
Third, the average prevalence: is between
2% and 8%
Second: combating infection routes
The ways of infection differ. In
countries with a high prevalence rate, the most common way of infection is from
the mother to the fetus.
In countries with low prevalence,
infection is through sexual contact.
As for countries with moderate
prevalence, infection is either through the mother to the fetus or through
sexual contact, or contaminated surgical instruments, dental tools, and blood
transfusions.
That is why it is important if we
want to protect healthy people to combat the ways of infection:
Protecting the fetus of a mother infected with hepatitis B:
It is important to do an HBV test
for all pregnant women. If the virus is active, the pregnant woman will take
treatment. It is also important after birth, to give the fetus the immunoglobulin
and vaccine immediately after birth in the first six hours to protect it from
infection with the B virus.
Protection from sexually transmitted infection:
It is also important in sexual
intercourse to adhere to religious teachings, whether Islamic or Christian,
which forbid adultery, adherence to the instructions for safe sex, the use of
condoms, and the vaccination of the uninfected husband or wife.
Protection from surgical infection:
For surgeries, it is very important
to sterilize the surgical tools well and the dentist’s tools, and currently the
patient can buy the kit tools that he takes with him to the dentist
Protection from household infection:
Likewise, everyone uses their own
shaving tools at the barbershop or at home. Sharing tools such as scissors,
clippers, razors, and toothbrushes can transmit the B virus.
If we follow these steps, we will be able to eliminate the B virus, as the World Health Organization announced, that by 2030 there will be no B virus patients, and this dream will not be achieved except by following the previous steps.
Conclusion
HBV infects about a quarter of a
billion people out of the total world population, and the World Health
Organization hopes that by 2030, the B virus will be completely eliminated by
following a plan and steps that include reducing transmission of infection and
providing treatment for patients.
.